REVB Q4 2025 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$5,852

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-1.65

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$8.3B

Free Cash Flow

-$8.3B

Stock-Based Comp.

$595M

Balance Sheet

Total Assets

$11.6B

Total Liabilities

$2.7B

Stockholders' Equity

$8.9B

Cash & Equivalents

$10.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$26,964	-100.0%
Gross Profit	-$5,852	$13,482	-143.4%
Operating Income	-$3M	-$2M	-46.6%
Net Income	-$3M	-$2M	-45.5%